Skip to Main Content

Author Details

Helen A Shih
Massachusetts General Hospital and Harvard Medical School
1997
196
47
PMIDPaper TitleJournal TitlePublished Year
35878716A Systematic Comparison of Dose Distributions Delivered in <sup>125</sup>I Plaque Brachytherapy and Proton Radiation Therapy for Ocular Melanoma.Int J Radiat Oncol Biol Phys2023
37693537Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy.bioRxiv2023
37210135The Role of Radiotherapy in the Treatment of Higher-Grade Meningioma.Neurosurg Clin N Am2023
36975476Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series.Curr Oncol2023
37173897Novel Mechanisms and Future Opportunities for the Management of Radiation Necrosis in Patients Treated for Brain Metastases in the Era of Immunotherapy.Cancers (Basel)2023
37437144BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.N Engl J Med2023
37268724Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results.Nat Med2023
37477853Health-related quality of life analyses in nonfunctioning pituitary macroadenoma patients identifies at-risk populations.Pituitary2023
37396599Incremental Learning for Heterogeneous Structure Segmentation in Brain Tumor MRI.ArXiv2023
36725170In Reply to Elmali and Yazici.Int J Radiat Oncol Biol Phys2023
36725165Protons or Photons - Let's Get It Done.Int J Radiat Oncol Biol Phys2023
36624600Labyrinthine Fluid Signal Intensity on T2-Weighted MR Imaging in Patients With Vestibular Schwannomas Undergoing Proton Radiotherapy: A Longitudinal Assessment.Otol Neurotol2023
33355171Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).Br J Ophthalmol2022
35589076A Comparison of Treatment Outcomes after Standard Dose (70 Gy) versus Reduced Dose (50 Gy) Proton Radiation in Patients with Uveal Melanoma.Ophthalmol Retina2022
36416771Case 36-2022: A 30-Year-Old Woman with Decreased Vision and Headache.N Engl J Med2022
35902341Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.Pract Radiat Oncol2022
35289329Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.Nat Commun2022
34919736Technical note: Does the greater power of pencil beam scanning reduce the need for a proton gantry? A study of head-and-neck and brain tumors.Med Phys2022
35121191The Insanity of Addiction and My Devotion to the Addicted.Pract Radiat Oncol2022
35114133Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities.Lancet Oncol2022
35053576The Alliance AMBUSH Trial: Rationale and Design.Cancers (Basel)2022
34898238Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.J Clin Oncol2022
35229827Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial.Neurosurgery2022
32750703Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.Neuro Oncol2021
33858474Current status and recent advances in resection cavity irradiation of brain metastases.Radiat Oncol2021
35122016Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations.Nat Cancer2021
34934865Dosimetric Comparison of Proton Versus Photon Radiosurgery for Treatment of Pituitary Adenoma.Adv Radiat Oncol2021
34642329Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.Nat Commun2021
34579983The Essential Anthony.Int J Radiat Oncol Biol Phys2021
34538850Outcome and Toxicity of Proton Therapy for Vestibular Schwannoma: A Cohort Study.Otol Neurotol2021
34387682Use of Involuntary Emergency Treatment by Physicians and Law Enforcement for Persons With High-Risk Drug Use or Alcohol Dependence.JAMA Netw Open2021
34221568Parkinsonism reversed from treatment of pineal non-germinomatous germ cell tumor.Surg Neurol Int2021
33989591In Reply to McClelland and Watson.Int J Radiat Oncol Biol Phys2021
34270765An early foray with targeted therapy and inspiring novel approaches to combat adult medulloblastoma.Neuro Oncol2021
34171846Accounting for uncertainties in the position of anatomical barriers used to define the clinical target volume.Phys Med Biol2021
33947781Clinical Presentation and Management of SMART Syndrome.Neurology2021
33482232Modelling of late side-effects following cranial proton beam therapy.Radiother Oncol2021
32777336Adjuvant Radiation Therapy Versus Surveillance After Surgical Resection of Atypical Meningiomas.Int J Radiat Oncol Biol Phys2021
32911019Brain Necrosis in Adult Patients After Proton Therapy: Is There Evidence for Dependency on Linear Energy Transfer?Int J Radiat Oncol Biol Phys2021
31563411Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.Radiother Oncol2020
31701682Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.Cancer Med2020
32084525Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.Int J Radiat Oncol Biol Phys2020
32028342ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy.Am J Clin Oncol2020
31839482The Interaction of Waiting Time and Patient Experience during Radiation Therapy: A Survey of Patients from a Tertiary Cancer Center.J Med Imaging Radiat Sci2020
31864558Intracranial Activity of Gefitinib and Capmatinib in a Patient with Previously Treated Non-Small Cell Lung Cancer Harboring a Concurrent EGFR Mutation and MET Amplification.J Thorac Oncol2020
31850601Proton therapy for head and neck paragangliomas: A single institutional experience.Head Neck2020
32034917Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival.Neuro Oncol2020
33427658Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813.Int J Radiat Oncol Biol Phys2020
32931399Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.J Clin Oncol2020
32921347Initial Approach to the Patient with Multiple Newly Diagnosed Brain Metastases.Neurosurg Clin N Am2020
  • 1 - 50 of 196

Recommended Authors

Matthew S Susko
University of California San Francisco
Career Start Year 2016
Number of shared co-authors 3
Erqi L Pollom
Stanford University
Career Start Year 2014
Number of shared co-authors 2
I-Chia Liu
University of Florida College of Medicine
Career Start Year 2013
Number of shared co-authors 0
Mohamed H Khattab
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 0
Johannes Kerschbaumer
Medical University of Innsbruck
Career Start Year 2012
Number of shared co-authors 3
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 0
Jeffrey Greenspoon
Juravinski Cancer Centre
Career Start Year 2011
Number of shared co-authors 2
David R Raleigh
University of California san francisco
Career Start Year 2010
Number of shared co-authors 10
William C Chen
University of California San Francisco
Career Start Year 2010
Number of shared co-authors 5
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year 2009
Number of shared co-authors 4
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year 2007
Number of shared co-authors 4
Nicholas Butowski
University of California san francisco
Career Start Year 2005
Number of shared co-authors 13
Joost J C Verhoeff
University Medical Center Utrecht
Career Start Year 2005
Number of shared co-authors 2
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 5
Analiz Rodriguez
University of Arkansas for Medical Sciences
Career Start Year 2004
Number of shared co-authors 3
Gelareh Zadeh
University of Toronto
Career Start Year 2003
Number of shared co-authors 20
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 2
Luke Pater
University of Cincinnati
Career Start Year 2002
Number of shared co-authors 1
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 8
Austin N Kirschner
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 0
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 0
Michelle Alonso-Basanta
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 3
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 3
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 6
Clark C Chen
University of Minnesota
Career Start Year 1994
Number of shared co-authors 9
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 3
Robert L Foote
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 4
Camilo E Fadul
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 8

Collaborators

Andrzej Niemierko
Massachusetts General Hospital
Co-authored papers 37
John P Kirkpatrick
Duke University Medical Center
Co-authored papers 22
Minesh P Mehta
Co-authored papers 19
Priscilla K Brastianos
Co-authored papers 15
Penny K Sneed
University of California San Francisco
Co-authored papers 13
Nancy U Lin
Co-authored papers 12
Steve E Braunstein
University of California san francisco
Co-authored papers 11
Tracy T Batchelor
Brigham and Women's Hospital
Co-authored papers 11
Brian V Nahed
Harvard Medical School
Co-authored papers 6
John H Suh
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 6
Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
Co-authored papers 6
Georges El Fakhri
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Co-authored papers 6
Yen-Lin Chen
34903Fu-Jen Catholic University
Co-authored papers 6
Patrick Y Wen
Co-authored papers 6
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers 5
Maria Martinez-Lage
Massachusetts General Hospital
Co-authored papers 4
Ian E Krop
Co-authored papers 4
Anthony J Iafrate
Massachusetts General Hospital
Co-authored papers 4
Xuping Zhu
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 4
Anat Stemmer-Rachamimov
Massachusetts General Hospital
Co-authored papers 4
Kathleen A Calzone
National Institutes of Health, National Cancer Institute, Center for Cancer Research
Co-authored papers 4
Robert J Weil
Rhode Island Hospital
Co-authored papers 4
Sara M Tolaney
Dana-Farber Cancer Institute
Co-authored papers 4
Scott L Carter
Co-authored papers 4
Kira Grogg
Gordon Center for Medical Imaging, Massachusetts General Hospital
Co-authored papers 4
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 4
Eric F Grabowski
Massachusetts General Hospital
Co-authored papers 3
David Schiff
University of Virginia School of Medicine
Co-authored papers 3
Anne-Marie Martin
Novartis Pharmaceuticals
Co-authored papers 3
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 3
Release 1.2